Replies to post #70340 on Biotech Values

[DewDiligence]

The big unanswered question: Will the anti-platelet market become largely genericized when Plavix goes off-patent in three years, or will it remain a blockbuster segment where new branded drugs pick up the slack?

I lean toward the former… what about you?

[DewDiligence]

As had been rumored, Prasugrel will have an FDA advisory panel on Feb 3:

http://finance.yahoo.com/news/FDA-Cardio-Renal-Advisory-prnews-13942254.html